CompBrief BY VELARION

Companies Dice Therapeutics, Inc.

Dice Therapeutics CEO salary & total pay, FY2022: $5.8M

Dice Therapeutics (DICE) CEO salary, fiscal 2022: J. Kevin Judice was paid a salary of $540,000 and $5,773,577 in total compensation. Free brief. Every figure links to the company’s own filing.

Dice Therapeutics, Inc. no longer files a proxy statement; its last pay data is FY2022.

All products and prices

J. Kevin Judice's complete compensation dossier

A PDF and a CSV sent to your email: J. Kevin Judice's pay in every fiscal year Dice Therapeutics, Inc. reported it, line by line, with J. Kevin Judice's equity grants and Dice Therapeutics, Inc.'s disclosed peer group where the company discloses them. Every row is cited to its filing.

One-time report. No refunds.

See an example →
CEO total pay$5,773,577CEO J. Kevin Judice · source

CEO pay, last three years

  • $5,561,963FY2021
  • $5,773,577FY2022

CEO total pay was $5,773,577 in fiscal 2022, up from $5,561,963 in fiscal 2021.

FY2022: salary $540,000 · bonus $0 · stock awards $0 · option awards $4,933,577

Executives and directors

Frequently asked questions

Who was the highest-paid executive at Dice Therapeutics, Inc. in fiscal 2022?
As disclosed, J. Kevin Judice (Chief Executive Officer) was the highest-paid executive at Dice Therapeutics, Inc. in fiscal 2022, with total compensation of $5,773,577.
How much does Dice Therapeutics, Inc. spend in total on board compensation for fiscal 2022?
As disclosed, Dice Therapeutics, Inc. reported total board compensation of $273,108 for fiscal 2022.

Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.

Full detail

Every table from the filing. Open any section.

Summary compensation table
Named executive officerSalaryBonusStock awardsOption awardsNon-equity incentivePension / NQDCAll otherTotal
J. Kevin Judice$540,000$0$0$4,933,577$300,000$0$0$5,773,577
Chief Executive Officer
Timothy Lu450,000002,022,088250,000002,722,088
Chief Medical Officer
Scott Robertson440,000001,977,149250,000002,667,149
Chief Business and Financial Officer

A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.

Three-year trend — total compensation per named executive

Named executive officerFY2022 totalFY2021 totalFY2020 totalΔ FY2021→2022
J. Kevin Judice$5,773,577$5,561,963—↑ +211,614
Timothy Lu2,722,0882,038,779—↑ +683,309
Scott Robertson2,667,1492,379,018—↑ +288,131

Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.

Incentive-plan design — the Compensation Discussion & Analysis

The company's compensation program is designed to attract, retain, and motivate highly qualified executives by providing competitive base salaries and annual cash bonuses tied to the achievement of corporate performance objectives, including research and development milestones and operational priorities.

CEO STI target (% of salary)—
CEO LTI target (% of salary)—
Independent consultant—
Clawback policytrue
Anti-hedgingtrue
Anti-pledgingfalse
Equity grants and outstanding awards

Grants of plan-based awards — fiscal year 2022

ExecutiveAwardGrant dateThresholdTargetGrantedMaximumGrant-date fair value
J. Kevin JudiceOPTION2022-04-14——384,900—$4,933,577
Timothy LuOPTION2022-04-14——157,756—2,022,088
Scott RobertsonOPTION2022-04-14——154,250—1,977,149

Vehicle mix — grant-date fair value by award type

Named executive officerTime-vested (RSU)Performance-vested (PSU)Options / SARs% performance-vested
J. Kevin Judice$0$0$4,933,5770.0%
Timothy Lu002,022,0880.0%
Scott Robertson001,977,1490.0%

% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.

Outstanding equity awards at fiscal year-end 2022

ExecutiveAwardExercisableShares unvestedExercise priceMarket value unvested
J. Kevin JudiceOption20,464—17—
J. Kevin JudiceRSU—167,102—5,213,582
J. Kevin JudiceOption123,469156,29317—
J. Kevin JudiceOption88,206296,69419.64—
Scott RobertsonRSU—416—12,979
Scott RobertsonRSU—12,058—376,210
Scott RobertsonRSU—21,163—660,286
Scott RobertsonRSU—7,255—226,356
Scott RobertsonOption61,32760,49317—
Scott RobertsonOption35,348118,90219.64—
Scott RobertsonOption7,191—17—
Timothy LuRSU—41,509—1,295,081
Timothy LuRSU—32,637—1,018,274
Timothy LuOption18,26013,04417—
Timothy LuOption26,65242,10817—
Timothy LuOption36,152121,60419.64—
Director compensation
DirectorCash feesStock awardsOption awardsNon-equity incentiveAll otherTotal
Mittie Doyle, M.DIndependent · Nominating and Corporate Governance · Research and Development$31,875$0$520,636——$552,511
Lisa BowersIndependent · Compensation31,8750520,636——552,511
Richard Scheller, Ph.DIndependent · Board Chair · Research and Development (Chair)66,8750305,001——371,876
Jim ScopaIndependent · Audit · Compensation (Chair)57,5000207,400——264,900
Sharon TetlowIndependent · Audit (Chair) · Nominating and Corporate Governance57,5000207,400——264,900
Jake Simson, Ph.DIndependent · Audit · Compensation · Research and Development24,0450207,400——231,445
Shaan C. Gandhi, M.D., D.PhilIndependent3,43800——3,438
Stephen Zachary, Ph.DIndependent · Departed during FY000———

Board fee structure and ownership guideline

Annual cash retainer$35,000
Annual equity retainer—
Per board meeting fee—
Committee chair fees (audit / comp / nom-gov)15,000 / 15,000 / 15,000
Stock ownership guideline—

Total cost of the board

ComponentFY2022
Cash retainers and fees$273,108
Equity awards (grant-date value)$0
All other compensation$0
Total cost of the board$273,108

Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.

Peer group, and who names Dice Therapeutics as a peer

Companies that benchmark against DICE

No companies currently name DICE as a compensation peer in their most recent disclosure.

This is the complete answer, not a partial one — the list is never padded.

Chief executive pay against the peer group

Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company’s own proxy statement.

RankCompanyFYChief executiveSalaryStock awardsOption awardsNon-equity incentiveTotal
1Dice Therapeutics, Inc.2022J. Kevin Judice$540,000$0$4,933,577$300,000$5,773,577

Each peer’s compensation is from its most recently filed proxy; fiscal years differ by company. Each peer’s figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.

Say-on-pay history and pay ratio
Meeting yearMeeting dateForAgainstAbstainSupportOutcome
20232023-06-07—————
20222022-06-07—————

Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year’s compensation.

Say-on-pay — history, company’s computation

Meeting yearMeeting dateApproval — company’s computation
20232023-06-07—a
20222022-06-07—b

a. Voting standard not stated in the filing.

b. Voting standard not stated in the filing.

Approval percentages are the company’s own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.

Insider trades since the proxy

Every insider equity transaction reported on Form 4 after the 2022 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.

InsiderRoleTransaction dateCodeSharesPriceValueSecuritySource
Jim ScopaDirector2023-05-01A6,923$0$0CommonForm 4 ↗
Jim ScopaDirector2023-05-01D6,92300CommonForm 4 ↗
Lu TimothyCMO2023-05-03D10,00037365,398CommonForm 4 ↗
J. Kevin JudiceDirector2023-05-03D13,69837499,977CommonForm 4 ↗
Scott RobertsonCFO & CBO2023-05-03D18,75037685,350CommonForm 4 ↗
Richard H. SchellerDirector2023-05-05D84,097393,238,205CommonForm 4 ↗
John R. JacobsenCSO2023-06-01D4,44331138,799CommonForm 4 ↗
John R. JacobsenCSO2023-06-01D14,30730433,645CommonForm 4 ↗
Northpond Ventures GP, LLCGreater-than-10% holder2023-06-22D523,5034724,342,890CommonForm 4 ↗
Northpond Ventures GP, LLCGreater-than-10% holder2023-06-22D1,969,3684791,575,612CommonForm 4 ↗
Jim ScopaDirector2023-07-11D30000CommonForm 4 ↗
Jim ScopaDirector2023-07-18D2,20000CommonForm 4 ↗
Jim ScopaDirector2023-08-02D2,20000CommonForm 4 ↗
Jim ScopaDirector2023-08-02D22000CommonForm 4 ↗
RA CAPITAL MANAGEMENT, L.P.—2023-08-09D21,250——Derivative, Class A CommonForm 4 ↗
RA CAPITAL MANAGEMENT, L.P.—2023-08-09D786,407——CommonForm 4 ↗
RA CAPITAL MANAGEMENT, L.P.—2023-08-09D7,070,205——CommonForm 4 ↗
Jim ScopaDirector2023-08-09D15,199——CommonForm 4 ↗
Sharon TetlowDirector2023-08-09D21,250——Derivative, Class A CommonForm 4 ↗
Sharon TetlowDirector2023-08-09D13,800——Derivative, Class A CommonForm 4 ↗
Sharon TetlowDirector2023-08-09D8,261——Derivative, Class A CommonForm 4 ↗
Sharon TetlowDirector2023-08-09D12,096——Derivative, Class A CommonForm 4 ↗
Sharon TetlowDirector2023-08-09D49,841——CommonForm 4 ↗
John R. JacobsenCSO2023-08-09D154,250——Derivative, Class A CommonForm 4 ↗
John R. JacobsenCSO2023-08-09D46,324——Derivative, Class A CommonForm 4 ↗
John R. JacobsenCSO2023-08-09D11,064——Derivative, Class A CommonForm 4 ↗
John R. JacobsenCSO2023-08-09D7,579——Derivative, Class A CommonForm 4 ↗
John R. JacobsenCSO2023-08-09D14,341——Derivative, Class A CommonForm 4 ↗
John R. JacobsenCSO2023-08-09D4,408——Derivative, Class A CommonForm 4 ↗
John R. JacobsenCSO2023-08-09D1,344——Derivative, Class A CommonForm 4 ↗
John R. JacobsenCSO2023-08-09D4,229——Derivative, Class A CommonForm 4 ↗
John R. JacobsenCSO2023-08-09D1,278——Derivative, Class A CommonForm 4 ↗
John R. JacobsenCSO2023-08-09D922——Derivative, Class A CommonForm 4 ↗
John R. JacobsenCSO2023-08-09D4,367——Derivative, Class A CommonForm 4 ↗
John R. JacobsenCSO2023-08-09D147,497——CommonForm 4 ↗
Richard H. SchellerDirector2023-08-09D31,250——Derivative, Class A CommonForm 4 ↗
Richard H. SchellerDirector2023-08-09D22,600——Derivative, Class A CommonForm 4 ↗
Richard H. SchellerDirector2023-08-09D8,261——Derivative, Class A CommonForm 4 ↗
Richard H. SchellerDirector2023-08-09D9,138——Derivative, Class A CommonForm 4 ↗
Richard H. SchellerDirector2023-08-09D4,357——Derivative, Class A CommonForm 4 ↗
Richard H. SchellerDirector2023-08-09D8,427——CommonForm 4 ↗
Jake SimsonDirector2023-08-09D21,250——Derivative, Class A CommonForm 4 ↗
Jim ScopaDirector2023-08-09D21,250——Derivative, Class A CommonForm 4 ↗
Jim ScopaDirector2023-08-09D13,800——Derivative, Class A CommonForm 4 ↗
Jim ScopaDirector2023-08-09D8,261——Derivative, Class A CommonForm 4 ↗
Jim ScopaDirector2023-08-09D12,096——Derivative, Class A CommonForm 4 ↗
Jim ScopaDirector2023-08-09D25,722——CommonForm 4 ↗
Scott RobertsonCFO & CBO2023-08-09D18,750——Derivative, Class A CommonForm 4 ↗
Scott RobertsonCFO & CBO2023-08-09D112,500——Derivative, Class A CommonForm 4 ↗
Scott RobertsonCFO & CBO2023-08-09D154,250——Derivative, Class A CommonForm 4 ↗
Scott RobertsonCFO & CBO2023-08-09D56,920——Derivative, Class A CommonForm 4 ↗
Scott RobertsonCFO & CBO2023-08-09D15,000——Derivative, Class A CommonForm 4 ↗
Scott RobertsonCFO & CBO2023-08-09D16,595——Derivative, Class A CommonForm 4 ↗
Scott RobertsonCFO & CBO2023-08-09D9,095——Derivative, Class A CommonForm 4 ↗
Scott RobertsonCFO & CBO2023-08-09D2,688——Derivative, Class A CommonForm 4 ↗
Scott RobertsonCFO & CBO2023-08-09D20,751——Derivative, Class A CommonForm 4 ↗
Scott RobertsonCFO & CBO2023-08-09D771——Derivative, Class A CommonForm 4 ↗
Scott RobertsonCFO & CBO2023-08-09D7,191——Derivative, Class A CommonForm 4 ↗
Scott RobertsonCFO & CBO2023-08-09D198,000——CommonForm 4 ↗
Lisa BowersDirector2023-08-09D42,500——Derivative, Class A CommonForm 4 ↗
Lu TimothyCMO2023-08-09D15,000——Derivative, Class A CommonForm 4 ↗
Lu TimothyCMO2023-08-09D90,000——Derivative, Class A CommonForm 4 ↗
Lu TimothyCMO2023-08-09D157,756——Derivative, Class A CommonForm 4 ↗
Lu TimothyCMO2023-08-09D43,167——Derivative, Class A CommonForm 4 ↗
Lu TimothyCMO2023-08-09D25,593——Derivative, Class A CommonForm 4 ↗
Lu TimothyCMO2023-08-09D31,304——Derivative, Class A CommonForm 4 ↗
Lu TimothyCMO2023-08-09D152,285——CommonForm 4 ↗
Mittie DoyleDirector2023-08-09D42,500——Derivative, Class A CommonForm 4 ↗
J. Kevin JudiceDirector2023-08-09D50,000——Derivative, Class A CommonForm 4 ↗
J. Kevin JudiceDirector2023-08-09D300,000——Derivative, Class A CommonForm 4 ↗
J. Kevin JudiceDirector2023-08-09D384,900——Derivative, Class A CommonForm 4 ↗
J. Kevin JudiceDirector2023-08-09D132,074——Derivative, Class A CommonForm 4 ↗
J. Kevin JudiceDirector2023-08-09D131,027——Derivative, Class A CommonForm 4 ↗
J. Kevin JudiceDirector2023-08-09D16,661——Derivative, Class A CommonForm 4 ↗
J. Kevin JudiceDirector2023-08-09D20,464——Derivative, Class A CommonForm 4 ↗
J. Kevin JudiceDirector2023-08-09D799,685——CommonForm 4 ↗
John R. JacobsenCSO2023-08-09D15,000——Derivative, Class A CommonForm 4 ↗
John R. JacobsenCSO2023-08-09D90,000——Derivative, Class A CommonForm 4 ↗

Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.

Sources (98 citations)

Each figure is listed with the filing it comes from, where it appears in that filing, and the value as printed. Any figure can be independently confirmed against the source.

  • Section 01, J. Kevin Judice. DEF 14A, filed 2023-04-26. Section “Executive Compensation” · page 23. As printed: 5,773,577. View filing ↗
  • Section 01, Timothy Lu. DEF 14A, filed 2023-04-26. Section “Executive Compensation” · page 23. As printed: 2,722,088. View filing ↗
  • Section 01, Scott Robertson. DEF 14A, filed 2023-04-26. Section “Executive Compensation” · page 23. As printed: 2,667,149. View filing ↗
  • Section 03, J. Kevin Judice OPTION. DEF 14A, filed 2023-04-26. Section “Executive Compensation” · grants of plan-based awards table. View filing ↗
  • Section 03, Timothy Lu OPTION. DEF 14A, filed 2023-04-26. Section “Executive Compensation” · grants of plan-based awards table. View filing ↗
  • Section 03, Scott Robertson OPTION. DEF 14A, filed 2023-04-26. Section “Executive Compensation” · grants of plan-based awards table. View filing ↗
  • Section 08, Mittie Doyle, M.D. DEF 14A, filed 2023-04-26. Section “Director Compensation”. As printed: 552,511. View filing ↗
  • Section 08, Lisa Bowers. DEF 14A, filed 2023-04-26. Section “Director Compensation”. As printed: 552,511. View filing ↗
  • Section 08, Richard Scheller, Ph.D. DEF 14A, filed 2023-04-26. Section “Director Compensation”. As printed: 371,876. View filing ↗
  • Section 08, Jim Scopa. DEF 14A, filed 2023-04-26. Section “Director Compensation”. As printed: 264,900. View filing ↗
  • Section 08, Sharon Tetlow. DEF 14A, filed 2023-04-26. Section “Director Compensation”. As printed: 264,900. View filing ↗
  • Section 08, Jake Simson, Ph.D. DEF 14A, filed 2023-04-26. Section “Director Compensation”. As printed: 231,445. View filing ↗
  • Section 08, Shaan C. Gandhi, M.D., D.Phil. DEF 14A, filed 2023-04-26. Section “Director Compensation”. As printed: 3,438. View filing ↗
  • Section 08, Stephen Zachary, Ph.D. DEF 14A, filed 2023-04-26. Section “Director Compensation”. As printed: —. View filing ↗
  • Section 02, Jim Scopa 2023-05-01. Form 4, filed 2023-05-02. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Jim Scopa 2023-05-01. Form 4, filed 2023-05-02. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Lu Timothy 2023-05-03. Form 4, filed 2023-05-05. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, J. Kevin Judice 2023-05-03. Form 4, filed 2023-05-05. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Scott Robertson 2023-05-03. Form 4, filed 2023-05-05. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Richard H. Scheller 2023-05-05. Form 4, filed 2023-05-09. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, John R. Jacobsen 2023-06-01. Form 4, filed 2023-06-02. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, John R. Jacobsen 2023-06-01. Form 4, filed 2023-06-02. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Northpond Ventures GP, LLC 2023-06-22. Form 4, filed 2023-06-23. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Northpond Ventures GP, LLC 2023-06-22. Form 4, filed 2023-06-23. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Jim Scopa 2023-07-11. Form 4, filed 2023-07-13. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Jim Scopa 2023-07-18. Form 4, filed 2023-07-19. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Jim Scopa 2023-08-02. Form 4, filed 2023-08-03. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Jim Scopa 2023-08-02. Form 4, filed 2023-08-03. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, RA CAPITAL MANAGEMENT, L.P. 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, RA CAPITAL MANAGEMENT, L.P. 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, RA CAPITAL MANAGEMENT, L.P. 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Jim Scopa 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Sharon Tetlow 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Sharon Tetlow 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Sharon Tetlow 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Sharon Tetlow 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Sharon Tetlow 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, John R. Jacobsen 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, John R. Jacobsen 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, John R. Jacobsen 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, John R. Jacobsen 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, John R. Jacobsen 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, John R. Jacobsen 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, John R. Jacobsen 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, John R. Jacobsen 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, John R. Jacobsen 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, John R. Jacobsen 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, John R. Jacobsen 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, John R. Jacobsen 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Richard H. Scheller 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Richard H. Scheller 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Richard H. Scheller 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Richard H. Scheller 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Richard H. Scheller 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Richard H. Scheller 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Jake Simson 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Jim Scopa 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Jim Scopa 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Jim Scopa 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Jim Scopa 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Jim Scopa 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Scott Robertson 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Scott Robertson 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Scott Robertson 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Scott Robertson 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Scott Robertson 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Scott Robertson 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Scott Robertson 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Scott Robertson 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Scott Robertson 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Scott Robertson 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Scott Robertson 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Scott Robertson 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Lisa Bowers 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Lu Timothy 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Lu Timothy 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Lu Timothy 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Lu Timothy 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Lu Timothy 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Lu Timothy 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Lu Timothy 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, Mittie Doyle 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, J. Kevin Judice 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, J. Kevin Judice 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, J. Kevin Judice 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, J. Kevin Judice 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, J. Kevin Judice 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, J. Kevin Judice 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, J. Kevin Judice 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, J. Kevin Judice 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, John R. Jacobsen 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 02, John R. Jacobsen 2023-08-09. Form 4, filed 2023-08-09. Insider equity transaction reported since the proxy statement. View filing ↗
  • Section 06, 2023 vote. Form 8-K, filed 2023-06-07. Item 5.07 · say-on-pay result. As reported: —. View filing ↗
  • Section 06, 2022 vote. Form 8-K, filed 2022-06-08. Item 5.07 · say-on-pay result. As reported: —. View filing ↗
  • Section 01 trend, Δ column (computed). Computed. Δ = current-FY total − prior-FY total per named officer.
  • Section 03b vehicle mix (computed). Computed. RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).
  • Section 09b board cost (computed). Computed. Cash 273,108 + equity 0 + all other 0 = 273,108, summed across the director compensation table rows.
  • Dice Therapeutics, Inc. (subject), Section 10b CEO total. DEF 14A, filed 2023-04-26. CEO total compensation as printed in Dice Therapeutics, Inc.'s own proxy. As printed: 5,773,577. View filing ↗